Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine — RIVER-EU  

Knowledge, Attitudes, Practice Clinical Trial

Official title: Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine Uptake in Underserved Communities in Greece, The Netherlands, Poland and Slovakia

Status Not yet recruiting

Clinical Trial Summary

The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV & MMR vaccines among underserved communities across four European countries: Greece, Netherlands, Poland, and Slovakia. The interventions will target identified health systems barriers in an earlier phase of the project. The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups. In addition, the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated. The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?

Clinical Trial Description

The general objective of the study is to improve access to vaccination by addressing relevant system level barriers to increase HPV and MMR (where applicable) vaccine intention and uptake among the target groups. The investigators expect that the intervention will address health system barriers to improve increase in access to information on vaccination and vaccination services. A prospective multicomponent intervention study will be performed between 1st of April 2024 and 31st of July 2025 that will be evaluated using a pre and post design as well as a participatory approach during the implementation. As part of the multicomponent intervention a preparatory phase is taken place before this period of time. The multicomponent intervention consists of training of health promotors and healthcare professionals, and of educational sessions to community members and navigation. The educational sessions will be offered at suitable and accessible locations for the target population. The five communities targeted in are the following: 1. The migrant community in Greece (HPV and MMR) 2. Turkish and Moroccan women in the Netherlands (HPV) 3. The Ukrainian community in Poland (HPV and MMR) 4. The Roma community in Slovakia (HPV) ;

Related Conditions & MeSH terms

• Knowledge, Attitudes, Practice
• Vaccination

• NCT number: NCT06361628
• Study type: Interventional
• Source: University Medical Center Groningen
• Contact: Janine De Zeeuw, PhD
• Phone: +31 645552994
• Email: j.de.zeeuw@umcg.nl
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 1, 2024
• Completion date: June 1, 2025